Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
SOUTH JORDAN, Utah, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional,...
-
Prospective, observational study published in CardioVascular and Interventional Radiology1 reports 100% target lesion primary patency (“TLPP”) rate without reintervention through 30 days, with a...
-
SOUTH JORDAN, Utah, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in...
-
Q2 2021 reported revenue of $280.3 million, up 28.4% compared to Q2 2020Q2 2021 constant currency revenue, organic* up 25.5% compared to Q2 2020Q2 2021 GAAP EPS of $0.09, compared to GAAP loss per...
-
SOUTH JORDAN, Utah, July 09, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional,...
-
Q1 2021 reported revenue of $248.9 million, up 2.2% compared to Q1 2020Q1 2021 constant currency revenue, organic* up 0.6% compared to Q1 2020Q1 2021 GAAP EPS of $0.19, compared to GAAP loss per share...
-
SOUTH JORDAN, Utah, April 09, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional,...
-
SOUTH JORDAN, Utah, April 08, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in...
-
SOUTH JORDAN, Utah, March 11, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in...
-
Q4 2020 reported revenue of $258.0 million, approximately equal to Q4 2019 revenueQ4 2020 core revenue on a constant currency basis* down (1.0)% compared to Q4 2019Q4 2020 GAAP EPS of $0.27, compared...